Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-093784

Chief Financial Officer sold 11,655 shares at an average $13.08 ($152,432)

  • Chief Financial Officer acquired 5,972 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WENTWORTH KORY JAMES · Chief Financial Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-19 Exercise or conversion : show line 1 in the form +4,452 $2.10 $9,349 24,673 D
2022-08-19 Sale : show line 2 in the form −8,529 $13.08 $111,530 16,144 D
2022-08-22 Exercise or conversion : show line 3 in the form +117 $2.10 $246 16,261 D
2022-08-22 Sale : show line 4 in the form −217 $13.00 $2,822 16,044 D
2022-08-23 Exercise or conversion : show line 5 in the form +1,403 $2.10 $2,946 17,447 D
2022-08-23 Sale : show line 6 in the form −2,909 $13.09 $38,080 14,538 D
Open-market sales · 11,655 sh · avg $13.08 · $152,432

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-08-19 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −4,452 111,444 D
2022-08-22 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −117 111,327 D
2022-08-23 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −1,403 109,924 D
Loading xslF345X03/tm2224405-1_4seq1.xml…